1, 3, 5-trisubstituted pyrazole compound and preparation method thereof

By performing addition cyclization reaction of hydrazine compounds and α-bromoketone compounds under the action of a photocatalyst under light conditions, the preparation method of 1,3,5-trisubstituted pyrazole compounds in the prior art was solved. The complex process and harsh conditions have achieved an efficient and economical preparation process, and the product is highly purified and suitable for pharmaceutical and pesticide applications.

CN118930487AActive Publication Date: 2024-11-12GANNAN NORMAL UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410988838.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12
Estimated Expiration
2044-07-23

AI Technical Summary

Technical Problem

The existing preparation methods for 1,3,5-trisubstituted pyrazole compounds have problems such as complex processes, harsh conditions, and limited substrate range, and require the use of high concentrations of oxygen and high reaction temperature.

Method used

Addition cyclization reaction under light conditions was performed using hydrazine compounds, α-bromoketone compounds, photocatalysts, basic compounds and polar organic solvents to obtain 1,3,5-trisubstituted pyrazole compounds. Commercial raw materials, cheap and easy to obtain, simple process, mild conditions, no oxidant use, good substrate tolerance.

Benefits of technology

One step of reaction can obtain the target product, with high reaction efficiency and economical steps, with a yield of 43-82%, and a purity of up to 98.5-99.9%. It is suitable for skeleton materials for drugs and pesticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004959576830000011
    Figure BDA0004959576830000011
  • Figure BDA0004959576830000021
    Figure BDA0004959576830000021
  • Figure BDA0004959576830000022
    Figure BDA0004959576830000022
Patent Text Reader

Abstract

The invention belongs to the technical field of organic synthesis, and particularly relates to a 1, 3, 5-trisubstituted pyrazole compound and a preparation method thereof. The preparation method of the 1, 3, 5-trisubstituted pyrazole compound provided by the invention comprises the following steps: mixing a hydrazine compound, an alpha-bromoketone compound, a photocatalyst, an alkaline compound, an additive and a polar organic solvent, and carrying out an addition cyclization reaction under an illumination condition to obtain the 1, 3, 5-trisubstituted pyrazole compound. The preparation method disclosed by the invention has the advantages of mild conditions, easiness in control, high reaction efficiency, economical steps, cheap and easily available raw materials, no use of an oxidizing agent, good tolerance of functional groups and the like, and the prepared 1, 3, 5-trisubstituted pyrazole compound has relatively high purity which is 98.5-99.9% and has relatively high market popularization value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic synthesis, and specifically relates to a 1,3,5-trisubstituted pyrazole compound and a preparation method thereof. Background Art

[0002] 1,3,5-trisubstituted pyrazole compounds are often used as the skeleton of certain medicines and pesticides, and they play a very important role in the research and development of medicines and pesticides. For example, celecoxib and chloranil are a class of non-steroidal anti-inflammatory drugs used to treat pain or inflammation; tepoxalin is a veterinary analgesic with strong anti-inflammatory activity; SC-560 has good anticancer activity; cyclopropanecarb and fipronil are a class of highly effective insecticides; due to their good biological activity and synthetic applications, the construction of 1,3,5-trisubstituted pyrazole skeletons has attracted great attention in recent years.

[0003] At present, the methods for synthesizing 1,3,5-trisubstituted pyrazole derivatives mainly include:

[0004] (a) Florian Pünner et al. (Florian Pünner, Yoshihiro Sohtome, Mikiko Sodeoka. Solvent-dependent copper-catalyzed synthesis of pyrazoles under aerobic conditions. [J]. Chemical Communications, 2016, 52(98): 14093-14096. DOI: 10.1039 / C6CC06935E) reported the synthesis of 1,3,5-trisubstituted pyrazoles from α,β-unsaturated hydrazones catalyzed by copper acetate, such as:

[0005]

[0006] However, the above synthesis method requires the use of pre-synthesized raw materials, and the raw material 1 must be synthesized before the next step can be performed. The operation process is cumbersome, and the material, time and labor costs are high. Moreover, high-concentration oxygen needs to be used as an oxidant, and the reaction conditions are harsh.

[0007] (b) Silja Hofmann et al. (Silja Hofmann, Martin Linden, Julian Neuner, Felix N. Weber, S,iegfried R. Waldvogel. Electrochemically enabled oxidative aromatization of pyrazolines [J]. Organic & Biomolecular Chemistry, 2023, 21 (22): 4694-4701. DOI: 10.1039 / D3OB00671A) reported the electrocatalytic generation of 1,3,5-trisubstituted pyrazolines into 1,3,5-trisubstituted pyrazoles, such as:

[0008]

[0009] This method also requires the use of pre-synthesized raw materials, the operation process is cumbersome, and requires a higher reaction temperature and harsh reaction conditions. At the same time, the increase in reaction temperature will cause the temperature-sensitive substrate to be unable to react.

[0010] (c) Liqiang Hao et al. (Liqiang Hao, Zhichao Wang, Yangyang Wang, Zhaoziyuan Yang, Xian Liu, Xiaobo Xua, Yafei Ji. Synthesis of pyrazoles from sulfonylhydrazone and benzyl acrylate under transition-metal-free conditions [J]. Organic & Biomolecular Chemistry, 2023, 21 (37): 7611-7615. DOI: 10.1039 / D3OB01172K.) reported the base-promoted generation of 1,3,5-trisubstituted pyrazoles from sulfonylhydrazone and benzyl acrylate, such as:

[0011]

[0012] This method also requires the use of pre-synthesized raw materials, the operation process is cumbersome, and requires a higher reaction temperature and harsh reaction conditions. At the same time, the increase in reaction temperature will cause the temperature-sensitive substrate to be unable to react.

[0013] At present, the preparation method of 1,3,5-trisubstituted pyrazole compounds has the defects of complex process, harsh conditions and limited substrate range. Summary of the invention

[0014] In view of this, the object of the present invention is to provide a 1,3,5-trisubstituted pyrazole compound and a preparation method thereof. The preparation method of the present invention uses commercial raw materials, which are cheap and easily available, and has a simple process, mild conditions, no oxidant, a wide range of substrates, and good functional group tolerance.

[0015] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0016] The present invention provides a method for preparing a 1,3,5-trisubstituted pyrazole compound, comprising the following steps:

[0017] A hydrazine compound, an α-bromoketone compound, a photocatalyst, a basic compound, an additive and a polar organic solvent are mixed, and an addition cyclization reaction is carried out under light conditions to obtain the 1,3,5-trisubstituted pyrazole compound;

[0018] The hydrazine compound has a structure shown in Formula I:

[0019]

[0020] R1 is an aryl group, a substituted aryl group or a heteroaryl group;

[0021] The α-bromoketone compound has a structure shown in Formula II:

[0022]

[0023] R2 is aryl, substituted aryl, heteroaryl or alkyl;

[0024] The 1,3,5-trisubstituted pyrazole compound has a structure shown in Formula III:

[0025]

[0026] The additive includes one or more of sodium benzenesulfinate, sodium 4-methylbenzenesulfinate and sodium 4-fluorobenzenesulfinate.

[0027] Preferably, the hydrazine compound includes one or more of phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-methoxyphenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-trifluoromethylphenylhydrazine, 3-methylphenylhydrazine, 2-fluorophenylhydrazine, 2-chlorophenylhydrazine, 2-bromophenylhydrazine, 2-methylphenylhydrazine, 2-hydrazinepyridine and 2-naphthyhydrazine.

[0028] Preferably, the α-bromo ketone compound includes one or more of 2-bromoacetophenone, 2-bromo-4'-(trifluoromethyl)acetophenone, 2-bromo-4'-fluoroacetophenone, 2-bromo-4'-chloroacetophenone, 2,4'-dibromoacetophenone, 2-bromo-4'-iodoacetophenone, 2-bromo-4'-methylacetophenone, 2-bromo-4'-methoxyacetophenone, 2,3'-dibromoacetophenone, 2-bromo-2'-chloroacetophenone, 2-bromo-3',4'-dimethoxyacetophenone, 2-bromo-5'-fluoro-2'-methoxyacetophenone, 2-(2-bromoacetyl)pyridine, 2-(2-bromoacetyl)thiophene, 2-(2-bromoacetyl)naphthalene and α-bromocyclopropylacetophenone.

[0029] Preferably, the molar ratio of the hydrazine compound to the α-bromoketone compound is 1:2-4.

[0030] Preferably, the photocatalyst includes a metal photocatalyst and / or a non-metal photocatalyst; the metal photocatalyst includes Ru(pby)3 and / or Ir[dF(CF3)ppy]2(dtbbpy)PF6; the non-metal photocatalyst includes one or more of Bengal Rose Red, Rhodamine B and 4CzIPN.

[0031] Preferably, the molar ratio of the hydrazine compound to the additive is 1:2-4.

[0032] Preferably, the illumination is 10W blue LED; the temperature of the addition cyclization reaction is room temperature, and the time is 12 to 24 hours.

[0033] Compared with the prior art, the present invention has the following beneficial effects:

[0034] The present invention provides a method for preparing a 1,3,5-trisubstituted pyrazole compound, comprising the following steps: mixing a hydrazine compound, an α-bromoketone compound, a photocatalyst, an alkaline compound, an additive and a polar organic solvent, and performing an addition cyclization reaction under light conditions to obtain the 1,3,5-trisubstituted pyrazole compound. The present invention performs an addition cyclization reaction on a hydrazine compound and an α-bromoketone compound under light conditions to obtain a 1,3,5-trisubstituted pyrazole compound. The preparation method of the present invention has the advantages of mild conditions, easy control, high reaction efficiency, economical steps, cheap and readily available raw materials, no use of oxidants, good functional group tolerance (hydrazines containing aromatic groups, substituted aromatic groups and heteroaromatic groups can all react with α-bromoketones), etc. The invention uses one or more of sodium benzenesulfinate, sodium 4-methylbenzenesulfinate and sodium 4-fluorobenzenesulfinate as additives, and can rapidly convert alpha-bromoketone into an intermediate. The intermediate can be converted into a 1,3,5-trisubstituted pyrazole compound with a hydrazine compound under light irradiation, and can promote the addition cyclization reaction. Compared with a multi-step synthesis reaction, the invention can obtain the target product in a one-step reaction, and the reaction yield reaches 43-82%, and has the advantages of high reaction efficiency and step economy.

[0035] Moreover, the 1,3,5-trisubstituted pyrazole compound prepared by the present invention has a high purity of 98.5-99.9%, and has a great market promotion value. DETAILED DESCRIPTION

[0036] The present invention provides a method for preparing a 1,3,5-trisubstituted pyrazole compound, comprising the following steps:

[0037] A hydrazine compound, an α-bromoketone compound, a photocatalyst, a basic compound, an additive and a polar organic solvent are mixed, and an addition cyclization reaction is carried out under light conditions to obtain the 1,3,5-trisubstituted pyrazole compound;

[0038] The hydrazine compound has a structure shown in Formula I:

[0039]

[0040] R1 is an aryl group, a substituted aryl group or a heteroaryl group;

[0041] The α-bromoketone compound has a structure shown in Formula II:

[0042]

[0043] R2 is aryl, substituted aryl, heteroaryl or alkyl;

[0044] The 1,3,5-trisubstituted pyrazole compound has a structure shown in Formula III:

[0045]

[0046] The additive includes one or more of sodium benzenesulfinate, sodium 4-methylbenzenesulfinate and sodium 4-fluorobenzenesulfinate.

[0047] In the present invention, unless otherwise specified, the materials and equipment used are commercially available products in the art.

[0048] In the present invention, R1 is preferably phenyl, substituted phenyl, pyridyl or naphthyl, and the substituents in the substituted phenyl independently preferably include halogen, cyano, methoxy, trifluoromethyl or methyl, and the halogen preferably includes fluorine, chlorine, bromine or iodine; the hydrazine compound preferably includes phenylhydrazine, substituted phenylhydrazine or naphthylhydrazine, and more preferably includes one or more of phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-methoxyphenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-trifluoromethylphenylhydrazine, 3-methylphenylhydrazine, 2-fluorophenylhydrazine, 2-chlorophenylhydrazine, 2-bromophenylhydrazine, 2-methylphenylhydrazine, 2-hydrazinylpyridine and 2-naphthylhydrazine.

[0049] In the present invention, the R2 is preferably phenyl, substituted phenyl, pyridyl, thienyl, naphthyl or cycloalkyl, the substituents in the substituted phenyl independently preferably include halogen, cyano, methoxy, trifluoromethyl or methyl, the halogen preferably includes fluorine, chlorine, bromine or iodine; the cycloalkyl preferably includes cyclopropane, the α-bromo ketone compound preferably includes 2-bromoacetophenone, 2-bromo-4'-(trifluoromethyl)acetophenone, 2-bromo-4'-fluoroacetophenone, 2-bromo-4'-chloroacetophenone, One or more of 2-(2-bromoacetyl)pyridine, 2-(2-bromoacetyl)thiophene, 2-(2-bromoacetyl)naphthalene and α-bromocyclopropylacetophenone.

[0050] In the present invention, the molar ratio of the hydrazine compound to the α-bromoketone compound is preferably 1:2-4, more preferably 1:4.

[0051] In the present invention, the photocatalyst preferably includes a metal photocatalyst and / or a non-metal photocatalyst; the metal photocatalyst preferably includes Ru(pby)3 and / or Ir[dF(CF3)ppy]2(dtbbpy)PF6; the non-metal photocatalyst preferably includes one or more of Bengal Rose Red, Rhodamine B and 4CzIPN.

[0052] In the present invention, the molar ratio of the hydrazine compound to the photocatalyst is preferably 1:0.01 to 0.05, and more preferably 1:0.01 to 0.02.

[0053] In the present invention, the alkaline compound preferably includes an inorganic alkaline compound and / or an organic alkaline compound; the inorganic alkaline compound preferably includes one or more of potassium carbonate, potassium hydroxide, potassium phosphate and dipotassium hydrogen phosphate; the organic alkaline compound preferably includes one or more of 1,8-diazabicyclo[5.4.0]undec-7-ene, diethylamine and triethylamine. The present invention utilizes the alkaline compound to provide an alkaline environment.

[0054] In the present invention, the molar ratio of the hydrazine compound to the basic compound is preferably 1:2-4.

[0055] In the present invention, the polar organic solvent preferably includes one or more of N,N-dimethylformamide, acetonitrile, tetrahydrofuran, dichloromethane and ethanol.

[0056] In the present invention, the usage ratio of the polar organic solvent to the hydrazine compound is preferably 1L:0.05-0.2mol, more preferably 1L:0.05-0.1mol.

[0057] In the present invention, the molar ratio of the hydrazine compound to the additive is preferably 1:2 to 4. The additive can promote the conversion of α-bromoketone compounds into trans-1,4-enedione, and then dehydrate and cyclize with hydrazine compounds to generate 1,3,5-trisubstituted pyrazole compounds, and the process can be completed quickly in one step. Taking Example 1 as an example, the additive sodium benzenesulfinate can react with 2-bromoacetophenone to generate an intermediate of the pyrazole product: 2-benzenesulfonylacetophenone (CAS: 3406-03-9), 2-benzenesulfonylacetophenone (CAS: 3406-03-9) can react with 2-bromoacetophenone to convert into an intermediate trans-1,2-dibenzoylethylene (CAS: 959-28-4), which can be converted into a 1,3,5-trisubstituted pyrazole compound with hydrazine under light. The additive of the present invention can improve the yield of 1,3,5-trisubstituted pyrazole compounds. When no additive is involved, the yield of 1,3,5-trisubstituted pyrazole compounds is only a trace amount.

[0058] The present invention has no particular limitation on the mixing process, and the materials can be mixed uniformly according to a process well known in the art.

[0059] In the present invention, the illumination is preferably a 10W blue LED, and the light source of the illumination is preferably a photocatalytic reactor (WP-TEC-1020), provided by Xi'an Huatai Cos Co., Ltd. The temperature of the addition cyclization reaction is preferably room temperature, and the time is preferably 12 to 24 hours, more preferably 18 to 24 hours. The addition cyclization reaction is preferably carried out under stirring conditions. The present invention has no special limitation on the stirring rate, and the reaction can be carried out smoothly according to the process well known in the art.

[0060] In the present invention, after the addition cyclization reaction, it is preferred to further include: purifying the obtained product system, the purification method is preferably column chromatography, the column chromatography preferably uses a silica gel column, and the eluent used for the column chromatography is preferably a mixed solvent of petroleum ether and ethyl acetate; the volume ratio of petroleum ether to ethyl acetate in the mixed solvent is preferably 1 to 20:1, more preferably 5 to 15:1. The present invention has no special limitation on the specific process of the column chromatography, and a method well known to those skilled in the art can be used. The present invention uses petroleum ether and ethyl acetate as eluents for purification, and can obtain a target compound with high purity.

[0061] In the present invention, the purity of the 1,3,5-trisubstituted pyrazole compound is preferably 98.5-99.9%, and the yield is preferably 43-82%.

[0062] The present invention also provides a 1,3,5-trisubstituted pyrazole compound, the structural formula of which is shown in any of the following structures:

[0063]

[0064]

[0065] The 1,3,5-trisubstituted pyrazole compounds of the present invention can be used as drug intermediates or skeleton materials for medicines and pesticides.

[0066] In order to further illustrate the present invention, the 1,3,5-trisubstituted pyrazole compounds and the preparation method thereof provided by the present invention are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.

[0067] Example 1

[0068] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0069]

[0070] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 76% and a purity of 99.9%;

[0071] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0072] 1 H NMR (400MHz, CDCl3, ppm) δ7.99(d,J=7.3Hz,2H),7.92(d,J=7.1Hz,2H),7.63(d,J=7.4H z,1H),7.52(t,J=7.8Hz,4H),7.45(t,J=6.3Hz,4H),7.38(t,J=7.3Hz,2H),7.10(s,1H);

[0073] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.6,151.5,140.5,140.2,137.3,133.7,132.1,129.9,129.0,128.8,128.7,128.5,128.2,125.9,124.9,110.8;

[0074] MS(EI,70eV)m / z 324,295,247,105,77;

[0075] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 17 N2O 325.1335, found 325.1366.

[0076] Example 2

[0077] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0078]

[0079] At room temperature, 0.1mmol 4-fluorophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 69% and a purity of 99.9%;

[0080] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0081] 1 H NMR (400MHz, CDCl3, ppm) δ7.98(d,J=6.8Hz,2H),7.89(d,J=7.1Hz,2H),7.65( t,J=7.5Hz,1H),7.54-7.42(m,6H),7.37(t,J=7.3Hz,1H),7.15-7.08(m,3H);

[0082] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.4,163.4,161.0,151.5,140.5,137.3,136.4,136.3, 133.7,132.0,129.8,128.8,128.7,128.6,126.9,126.8,126.0,116.0,115.8,110.9;

[0083] MS(EI,70eV)m / z 342,313,265,105,77;

[0084] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OF 343.1241, found 343.1271.

[0085] Example 3

[0086] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0087]

[0088] At room temperature, 0.1mmol 4-chlorophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 66% and a purity of 99.9%;

[0089] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0090] 1 H NMR (400MHz, CDCl3, ppm) δ7.99 (d, J = 7.7Hz, 2H), 7.89 (d, J = 7.6Hz, 2H), 7.67 (d, J = 7.5Hz, 1H), 7.53 (t, J = 7.7Hz, 3H), 7.46-7.35 (m, 6H), 7.09 (s, 1H);

[0091] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.4,151.7,140.4,138.7,137.2,134.0,133.9,131.9,129.9,129.1,128.9,128.8,128.7,126.2,125.9,111.1;

[0092] MS(EI,70eV)m / z 358,329,246,105,77;

[0093] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OCl 359.0946, found 359.0977.

[0094] Example 4

[0095] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0096]

[0097] At room temperature, 0.1mmol 4-bromophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 64% and a purity of 99.9%;

[0098] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0099] 1 H NMR (400MHz, CDCl3, ppm) δ7.99(d,J=7.2Hz,2H),7.89(d,J=7.0Hz,2H),7.66(d,J=7.5 Hz,1H),7.57-7.51(m,4H),7.43(d,J=7.6Hz,2H),7.38(d,J=8.8Hz,3H),7.09(s,1H);

[0100] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.4,151.8,140.4,139.2,137.1,133.8,132.1,131.9,129.9,128.9,128.8,128.7,126.4,125.9,122.0,111.2;

[0101] MS(EI,70eV)m / z 402,375,246,105,77;

[0102] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OBr 403.0441, found 403.0476.

[0103] Example 5

[0104] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0105]

[0106] At room temperature, 0.1mmol 4-cyanophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1 to obtain the purified target product with a yield of 70% and a purity of 99.9%;

[0107] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0108] 1 H NMR (400MHz, CDCl3, ppm) δ8.00(d,J=8.0Hz,2H),7.89(d,J=7.7Hz,2H),7.75- 7.61(m,5H),7.55(t,J=7.6Hz,2H),7.42(dt,J=23.5,7.4Hz,3H),7.13(s,1H);

[0109] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.3,152.5,143.3,140.6,136.8,134.2,133.0,131.5,129.9,129.0,128.9,126.0,125.1,118.3,112.2,111.5;

[0110] MS(EI,70eV)m / z 349,320,272,105,77;

[0111] HRMS (ESI) m / z [M+H] + Calculate for C 23 H 16 N3O 350.1288, found 350.1319.

[0112] Example 6

[0113] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0114]

[0115] At room temperature, 0.1mmol 4-methoxyphenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1, and the purified target product was obtained with a yield of 60% and a purity of 99.9%.

[0116] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0117] 1 H NMR (400MHz, CDCl3, ppm) δ7.98(d,J=7.2Hz,2H),7.90(d,J=7.4Hz,2H),7.63(d,J=7.6Hz,1H),7.52(d,J =7.6Hz,2H),7.45-7.40(m,4H),7.37(d,J=7.3Hz,1H),7.07(s,1H),6.94(d,J=8.9Hz,2H),3.83(s,3H);

[0118] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.6,159.4,151.1,140.4,137.4,133.6,13 3.4,132.2,129.8,128.8,128.6,128.4,126.3,125.9,114.2,110.4,55.6;

[0119] MS(EI,70eV)m / z 354,325,146,105,77;

[0120] HRMS (ESI) m / z [M+H] + Calculate for C 23 H 19 N2O2355.1441, found 355.1473.

[0121] Example 7

[0122] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0123]

[0124] At room temperature, 0.1mmol 3-chlorophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 65% and a purity of 99.9%;

[0125] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0126] 1 H NMR (400MHz, CDCl3, ppm) δ7.98(d,J=8.5Hz,2H),7.90(d,J=7.6Hz,2H),7.65(d,J=7.5Hz,1H ),7.58(s,1H),7.53(t,J=7.6Hz,2H),7.45(t,J=7.4Hz,2H),7.40-7.34(m,4H),7.10(s,1H);

[0127] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.3,151.8,141.1,140.6,137.1,134.6,133 .8,131.8,129.8,128.9,128.8,128.7,128.3,125.9,125.3,123.1,111.3;

[0128] MS(EI,70eV)m / z 358,329,246,105,77;

[0129] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OCl 359.0946, found 359.0978.

[0130] Example 8

[0131] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0132]

[0133] At room temperature, 0.1mmol 3-bromophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 64% and a purity of 99.9%;

[0134] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0135] 1 H NMR (400MHz, CDCl3, ppm) δ7.99(d,J=8.0Hz,2H),7.90(d,J=7.2Hz,2H),7.74(s,1H),7.67(t,J=7.5Hz,1 H),7.57-7.50(m,3H),7.45(t,J=7.4Hz,2H),7.39(d,J=7.4Hz,2H),7.29(d,J=8.0Hz,1H),7.10(s,1H);

[0136] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.3,151.9,141.2,140.6,137.1,133.8,131.8, 131.2,130.1,129.8,128.9,128.8,128.7,128.1,125.9,123.6,122.4,111.3;

[0137] MS(EI,70eV)m / z 402,375,246,105,77;

[0138] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OBr 403.0441, found 403.0476.

[0139] Example 9

[0140] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0141]

[0142] At room temperature, 0.1mmol 3-trifluoromethylphenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 67% and a purity of 99.9%;

[0143] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0144] 1 H NMR (400MHz, CDCl3, ppm) δ7.99(d,J=7.7Hz,2H),7.91(d,J=7.6Hz,2H),7.86(s,1H),7.65(d,J =8.2Hz,3H),7.54(t,J=7.5Hz,3H),7.46(t,J=7.5Hz,2H),7.40(d,J=7.2Hz,1H),7.14(s,1H);

[0145] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.3,152.1,140.6,140.6,137.1,133.9,131.7,131.4,129.8, 129.4,128.9,128.8,128.8,128.2,126.0,124.9,124.8,122.2,122.1,122.1,122.0,111.6;

[0146] MS(EI,70eV)m / z 392,363,315,105,77;

[0147] HRMS (ESI) m / z [M+H] + Calculate for C 23 H 16 N2OF3393.1209, found 393.1244.

[0148] Example 10

[0149] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0150]

[0151] At room temperature, 0.1mmol 3-methylphenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 53% and a purity of 99.9%;

[0152] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0153] 1 H NMR (400MHz, CDCl3, ppm) δ7.98(d,J=7.6Hz,2H),7.91(d,J=7.6Hz,2H),7.64(t,J=7.5Hz,1H),7.51(t,J=7.6Hz,2H),7.44(t,J =7.5Hz,2H),7.39-7.34(m,2H),7.29(t,J=7.7Hz,1H),7.23(d,J=7.9Hz,1H),7.19(d,J=7.4Hz,1H),7.08(s,1H),2.39(s,3H);

[0154] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.6,151.3,140.5,140.1,139.1,137.3,133.6,13 2.2,129.9,129.1,128.8,128.7,128.7,128.5,125.9,125.6,122.1,110.6,21.4;

[0155] MS(EI,70eV)m / z 338,323,261,105,77;

[0156] HRMS (ESI) m / z [M+H] + Calculate for C 23 H 19 N2O 339.1492, found 339.1522.

[0157] Embodiment 11

[0158] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0159]

[0160] At room temperature, 0.1mmol 2-fluorophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 66% and a purity of 99.9%;

[0161] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0162] 1 H NMR (400MHz, CDCl3, ppm) δ8.00(d,J=6.9Hz,2H),7.90(d,J=6.8Hz,2H),7.75-7.70(m,1H),7.65(t,J=7.4Hz,1H),7 .52(d,J=7.7Hz,2H),7.44(t,J=7.4Hz,2H),7.39(d,J=7.1Hz,2H),7.32(t,J=7.0Hz,1H),7.15(s,1H),7.10(s,1H);

[0163] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.1,165.4,157.0,154.5,154.0,152.1,141.6,137.1,133.5,132.2,132.0,130.0 ,129.9,129.8,128.9,128.8,128.6,127.7,127.1,125.9,124.8,124.8,121.9,116.4,116.2,115.0114.8,110.4;

[0164] MS(EI,70eV)m / z 342,323,265,105,77;

[0165] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OF 343.1241, found 343.1272.

[0166] Example 12

[0167] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0168]

[0169] At room temperature, 0.1mmol 2-chlorophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 65% and a purity of 99.9%;

[0170] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0171] 1 H NMR (400MHz, CDCl3, ppm) δ8.00 (d, J = 7.7Hz, 2H), 7.91 (d, J = 7.7Hz, 2H), 7.69-7.62 (m, 2H), 7.54-7.37 (m, 8H), 7.12 (s, 1H);

[0172] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.8,151.8,141.8,138.5,137.1,133.4,132 .0,130.9,130.1,130.0,129.8,129.1,128.8,128.6,127.7,126.0,110.0;

[0173] MS(EI,70eV)m / z 358,323,245,105,77;

[0174] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OCl 359.0946, found 359.0978.

[0175] Embodiment 13

[0176] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0177]

[0178] At room temperature, 0.1mmol 2-bromophenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 62% and a purity of 99.9%;

[0179] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0180] 1 H NMR (400MHz, CDCl3, ppm) δ8.00(d,J=7.2Hz,2H),7.90(d,J=7.4Hz,2H),7.65(t,J=7.9 Hz,3H),7.52(t,J=7.5Hz,3H),7.44(t,J=7.4Hz,2H),7.39-7.32(m,2H),7.11(s,1H);

[0181] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.7,151.7,141.6,140.1,137.1,133.4,133 .2,132.0,130.4,129.9,129.4,128.8,128.6,128.3,126.0,121.1,110.1;

[0182] MS(EI,70eV)m / z 402,375,246,105,77;

[0183] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 16 N2OBr 403.0441, found 403.0476.

[0184] Embodiment 14

[0185] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0186]

[0187] At room temperature, 0.1mmol 2-methylphenylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 47% and a purity of 99.9%.

[0188] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0189] 1 H NMR (400MHz, CDCl3, ppm) δ7.96(d,J=7.7Hz,2H),7.91(d,J=6.8Hz,2H),7.64(t,J=7.4Hz,1H),7.52( d,J=7.5Hz,2H),7.44(t,J=7.5Hz,2H),7.34(td,J=16.8,15.0,7.3Hz,5H),7.11(s,1H),2.17(s,3H);

[0190] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.8,151.1,141.3,139.8,137.5,135.2,133.4,132 .3,130.8,129.7,129.2,128.8,128.6,128.4,127.3,126.5,125.9,109.6,17.65;

[0191] MS(EI,70eV)m / z 338,233,206,105,77;

[0192] HRMS (ESI) m / z [M+H] + Calculate for C 23 H 19 N2O 339.1492, found 339.1526.

[0193] Embodiment 15

[0194] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0195]

[0196] At room temperature, 0.1mmol 2-hydrazinopyridine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1, and the purified target product was obtained with a yield of 43% and a purity of 99.9%;

[0197] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0198] 1 H NMR (400MHz, CDCl3, ppm) δ8.10 (d, J = 4.9Hz, 1H), 7.99-7.89 (m, 5H), 7.80 (t, J = 7.8Hz, 1 H),7.56(d,J=7.3Hz,1H),7.43(dt,J=15.2,7.3Hz,5H),7.12-7.07(m,1H),7.01(s,1H);

[0199] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ187.7,152.7,151.1,147.5,141.4,138.6,137 .4,133.3,132.1,129.4,128.8,128.7,128.5,126.1,122.0,115.0,108.5;

[0200] MS(EI,70eV)m / z 325,296,248,105,77;

[0201] HRMS (ESI) m / z [M+H] + Calculate for C 21 H 16 N3O 326.1288, found 326.1302.

[0202] Example 16

[0203] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0204]

[0205] At room temperature, 0.1mmol 2-naphthylhydrazine, 0.4mmol 2-bromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 50% and a purity of 99.9%;

[0206] 1 H NMR (400MHz, CDCl3, ppm) δ7.99-7.92(m,6H),7.56(dd,J=20.4,12.7Hz,5H),7.47(t,J=8.1Hz,5H),7.40(d,J=7.2Hz,1H),7.25(s,1H);

[0207] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.8,151.6,142.5,137.4,137.1,134.2,133.4,132.2,130. 4,129.7,129.6,128.9,128.6,128.3,127.4,126.6,126.0,125.03,124.98,122.6,109.8;

[0208] MS(EI,70eV)m / z 374,297,269,105,77;

[0209] HRMS (ESI) m / z [M+H] + Calculate for C 26 H 19 N2O 375.1492, found 375.1525.

[0210] Embodiment 17

[0211] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0212]

[0213] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-(trifluoromethyl)acetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 60% and a purity of 99.9%;

[0214] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0215] 1 H NMR (400MHz, CDCl3, ppm) δ8.07(d,J=8.1Hz,2H),8.01(d,J=8.1Hz,2H),7.78(d,J=8.1Hz,2H),7.70(d,J=8.2Hz,2H),7.47(q,J=7.5Hz,5H),7.15(s,1H);

[0216] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.1,150.2,140.2,140.0,139.8,135.3,135 .1,134.8,130.6,130.3,130.0,129.1,128.8,126.1,125.8,125.0,111.2;

[0217] MS(EI,70eV)m / z 460,444,429,165,77;

[0218] HRMS (ESI) m / z [M+H] + Calculate for C 24 H 15 N2OF6461.1083, found 461.1126.

[0219] Embodiment 18

[0220] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0221]

[0222] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-fluoroacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 64% and a purity of 99.9%;

[0223] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0224] 1 H NMR (400MHz, CDCl3, ppm) δ8.05-7.95(m,2H),7.95-7.81(m,2H),7.49-7.35(m,5H),7.15(dt,J=17.5,8.1Hz,4H),7.02(s,1H);

[0225] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.1,167.4,164.8,164.3,161.8,150.7,140.4,140.0,133.6,133.5,1 32.5,132.4,129.0,128.3,128.31,128.28,127.7,127.6,124.8,116.0,115.9,115.8,115.7,110.1;

[0226] MS(EI,70eV)m / z 360,331,265,123,77;

[0227] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 15 N2OF2361.1147, found 361.1180.

[0228] Embodiment 19

[0229] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0230]

[0231] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-chloroacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, column chromatography was performed for separation and purification. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 68% and a purity of 99.9%;

[0232] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0233] 1 H NMR (400MHz, CDCl3, ppm) δ7.90 (d, J = 8.6Hz, 2H), 7.83 (d, J = 8.5Hz, 2H), 7.51-7.44 (m, 5H), 7.41 (dt, J = 6.5, 4.8Hz, 4H), 7.04 (s, 1H);

[0234] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.2,150.5,140.3,139.9,135.5,134.4,131.2,130.5,129.1,129.0,128.5,127.1,124.9,110.4;

[0235] MS(EI,70eV)m / z 392,363,139,111,77;

[0236] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 15 N2OCl2393.0556, found 393.0591.

[0237] Embodiment 20

[0238] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0239]

[0240] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2,4'-dibromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 70% and a purity of 99.9%;

[0241] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0242] 1 H NMR (400MHz, CDCl3, ppm) δ7.82 (d, J = 8.4Hz, 2H), 7.76 (d, J = 8.3Hz, 2H), 7.64 (d, J = 8.4Hz, 2H), 7.56 (d, J = 8.5Hz, 2H), 7.49-7.36 (m, 5H), 7.03 (s, 1H);

[0243] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.4,150.5,140.3,139.9,135.9,132.1,132.0,131.2,131.0,129.1,128.5,127.4,124.9,122.6,119.1,110.4;

[0244] MS(EI,70eV)m / z 479,453,325,183,77;

[0245] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 15 N2OBr2480.9546,found 480.9589.

[0246] Embodiment 21

[0247] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0248]

[0249] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-iodoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, column chromatography was used for separation and purification. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 65% and a purity of 99.9%;

[0250] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0251] 1 H NMR (400MHz, CDCl3, ppm) δ7.97(d,J=7.3Hz,2H),7.76(d,J=8.3Hz,2H),7.65( d,J=8.4Hz,2H),7.50(dd,J=16.0,8.1Hz,4H),7.45-7.39(m,3H),7.06(s,1H);

[0252] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.5,150.4,140.7,140.0,137.9,137.2,133.8,131.7,129.9,129.0,128.7,128.4,127.6,124.9,110.5,94.2;

[0253] HRMS (ESI) m / z [M] + Calculate for C 22 H 14 N2OI2575.9190, found 575.9188.

[0254] Embodiment 22

[0255] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0256]

[0257] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-methylacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, column chromatography was used for separation and purification. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 82% and a purity of 99.9%;

[0258] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0259] 1 H NMR (400MHz, CDCl3, ppm) δ7.90(d,J=8.1Hz,2H),7.80(d,J=8.1Hz,2H),7.49(d,J=7.8Hz,2H),7.42(t,J=7.5Hz, 2H),7.37(d,J=7.3Hz,1H),7.30(d,J=7.9Hz,2H),7.25(d,J=8.1Hz,2H),7.04(s,1H),2.45(s,3H),2.40(s,3H);

[0260] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.5,151.5,144.7,140.6,140.2,138.3,134.8,130.1,129.5,129.4,129.0,128.0,125.8,124.8,110.3,21.8,21.4;

[0261] MS(EI,70eV)m / z 352,323,233,119,77;

[0262] HRMS (ESI) m / z [M+H] + Calculate for C 24 H 21 N2O 353.1648, found 353.1683.

[0263] Embodiment 23

[0264] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0265]

[0266] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-4'-methoxyacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1, and the purified target product was obtained with a yield of 73% and a purity of 99.9%;

[0267] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0268] 1 H NMR (400MHz, CDCl3, ppm) δ7.99(d,J=8.9Hz,2H),7.84(d,J=8.8Hz,2H),7.48(d,J=8.1Hz,2H) ,7.40(t,J=7.5Hz,2H),7.34(t,J=7.3Hz,1H),6.97(d,J=7.6Hz,5H),3.87(d,J=15.5Hz,6H);

[0269] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.6,164.2,159.9,151.3,140.8,140.2,132.3 ,130.1,129.0,127.9,127.2,125.0,124.6,114.2,114.0,109.5,55.6,55.4;

[0270] MS(EI,70eV)m / z 384,369,135,92,77;

[0271] HRMS (ESI) m / z [M+H] + Calculate for C 24 H 21 N2O3385.1547, found 385.1584.

[0272] Embodiment 24

[0273] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0274]

[0275] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2,3'-dibromoacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 67% and a purity of 99.9%;

[0276] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0277] 1 H NMR (400MHz, CDCl3, ppm) δ8.07 (s, 2H), 7.87 (d, J = 7.8Hz, 1H), 7.82 (d, J = 7.8Hz, 1 H),7.75(d,J=8.0Hz,1H),7.51-7.36(m,7H),7.31(t,J=7.8Hz,1H),7.07(s,1H);

[0278] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ183.9,150.1,140.1,139.8,138.9,136.6,134.0,132.6, 131.5,130.4,130.3,129.1,128.9,128.6,128.3,124.9,124.5,123.1,123.0,110.8;

[0279] MS(EI,70eV)m / z 479,453,325,183,77;

[0280] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 15 N2OBr2480.9546,found 480.9591.

[0281] Embodiment 25

[0282] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0283]

[0284] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-2'-chloroacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, column chromatography was used for separation and purification. The volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 62% and a purity of 99.9%;

[0285] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0286] 1 H NMR (400MHz, CDCl3, ppm) δ7.92 (d, J = 9.5Hz, 1H), 7.55 (t, J = 8.6Hz, 3H), 7.48-7.40 (m, 6H), 7.36-7.27 (m, 3H), 7.20 (s, 1H);

[0287] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.1,149.3,140.3,140.0,137.8,132.4,132.3,132.1, 130.9,130.7,130.5,130.4,130.0,129.6,128.9,128.6,127.0,126.8,125.5,115.7;

[0288] MS(EI,70eV)m / z 392,357,139,111,77;

[0289] HRMS (ESI) m / z [M+H] + Calculate for C 22 H 15 N2OCl2393.0556, found 393.0592.

[0290] Embodiment 26

[0291] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0292]

[0293] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-3',4'-dimethoxyacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1 to obtain the purified target product with a yield of 74% and a purity of 99.9%;

[0294] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0295] 1 H NMR (400MHz, CDCl3, ppm) δ7.66 (d, J = 8.4Hz, 1H), 7.53-7.46 (m, 4H), 7.40 (t, J = 7.9Hz, 3H) ,7.35(d,J=6.8Hz,1H),7.00(s,1H),6.92(dd,J=8.4,4.1Hz,2H),3.94(d,J=17.9Hz,12H);

[0296] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.7,154.1,151.3,149.5,149.3,140.8,140.1,130.1,129.0 ,128.0,125.5,125.3,124.6,118.6,111.34,111.25,110.0,109.5,108.9,56.2,56.1,56.0;

[0297] MS(EI,70eV)m / z 444,429,165,137,77;

[0298] HRMS (ESI) m / z [M+H] + Calculate for C 26 H 25 N2O5445.1758, found 445.1799.

[0299] Embodiment 27

[0300] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0301]

[0302] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-bromo-5'-fluoro-2'-methoxyacetophenone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1 to obtain the purified target product with a yield of 68% and a purity of 99.9%;

[0303] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0304] 1 H NMR (400MHz, CDCl3, ppm) δ7.85(dd,J=9.5,3.1Hz,1H),7.47(d,J=7.5Hz,2H),7.37(dt,J=13.5,6.7Hz,3H),7.29(s,1H),7.24(dd,J=8. 0,3.3Hz,1H),7.14-7.09(m,1H),7.02-6.97(m,1H),6.90(dd,J=9.1,4.4Hz,1H),6.79(dd,J=9.1,4.0Hz,1H),3.85(s,3H),3.70(s,3H);

[0305] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ184.1,158.4,157.7,156.0,155.3,154.2,153.2,147.5,141.7,140.0,129.1,129.0,128.7,128.2,125.2 ,124.4,122.4,122.3,120.5,119.6,119.4,116.9,116.6,115.5,115.3,115.1,114.8,114.5,112.9,112.8,112.6,112.5,56.3,56.1;

[0306] MS(EI,70eV)m / z 420,267,239,153,77;

[0307] HRMS (ESI) m / z [M+H] + Calculate for C 24 H 19 N2O3F2421.1358,found 421.1399.

[0308] Embodiment 28

[0309] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0310]

[0311] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-(2-bromoacetyl)pyridine, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 5:1 to obtain the purified target product with a yield of 54% and a purity of 99.9%;

[0312] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0313] 1 H NMR (400MHz, CDCl3, ppm) δ8.73(d,J=4.8Hz,1H),8.65(d,J=4.9Hz,1H),8.11(d,J=7.9Hz,1H),8.0 5-7.97(m,2H),7.85(t,J=7.7Hz,1H),7.73(t,J=7.7Hz,1H),7.53-7.41(m,6H),7.25-7.21(m,1H);

[0314] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ183.0,154.1,151.8,151.3,149.5,149.0,140.9, 139.8,137.1,136.7,128.8,128.4,127.0,125.6,124.0,123.0,120.4,114.5;

[0315] MS(EI,70eV)m / z 326,297,222,105,77;

[0316] HRMS (ESI) m / z [M+Na] + Calculate for C 20 H 14 N4ONa 349.1060,found 349.1093.

[0317] Embodiment 29

[0318] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0319]

[0320] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-(2-bromoacetyl)thiophene, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 49% and a purity of 99.9%;

[0321] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0322] 1 H NMR (400MHz, CDCl3, ppm) δ7.87(d,J=3.9Hz,1H),7.77(d,J=4.9Hz,1H),7.50-7.38(m,6H),7.32(d,J=5.1Hz,1H),7.21-7.17(m,1H),7.15-7.08(m,2H);

[0323] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ177.0,146.9,143.6,140.2,139.8,135.6,135.1,135.0,129.0,128.5,128.3,127.7,125.6,124.9,124.8,109.5;

[0324] MS(EI,70eV)m / z 336,319,253,111,77;

[0325] HRMS (ESI) m / z [M+H] + Calculate for C 18 H 13 N2OS2337.0464, found 337.0495.

[0326] Embodiment 30

[0327] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0328]

[0329] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol 2-(2-bromoacetyl)naphthalene, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, the reaction was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1, and the purified target product was obtained with a yield of 56% and a purity of 99.9%;

[0330] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0331] 1 H NMR (400MHz, CDCl3, ppm) δ8.58 (s, 1H), 8.39 (s, 1H), 8.13-8.05 (m, 2H), 8.00 (d, J = 11.3Hz, 2H), 7.90 (dd, J = 22.7, 11.3Hz, 4H), 7.67(d,J=7.0Hz,1H),7.59(d,J=7.7Hz,3H),7.50(d,J=3.2Hz,2H),7.45(t,J=6.6Hz,2H),7.39(d,J=8.5Hz,1H),7.29(s,1H);

[0332] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ185.7,151.5,140.9,140.2,135.9,134.7,133.6,133.4,132.33,132.28,129.8,129 .6,129.1,129.0,128.8,128.6,128.30,128.26,128.0,127.8,127.1,126.5,126.3,124.9,124.8,124.0,110.9;

[0333] MS(EI,70eV)m / z 424,297,195,127,77;

[0334] HRMS (ESI) m / z [M+H] + Calculate for C 30 H 21 N2O 425.1648, found 425.1687.

[0335] Embodiment 31

[0336] The 1,3,5-trisubstituted pyrazole compound obtained in this example has the following structure:

[0337]

[0338] At room temperature, 0.1mmol phenylhydrazine, 0.4mmol α-bromocyclopropylethyl ketone, 0.001mmol Bengal rose red as a photocatalyst, 0.4mmol potassium carbonate, 0.2mmol sodium benzenesulfinate and 2.0mL N,N-dimethylformamide were added to the reaction tube, and the reaction was stirred for 24h under a 10W blue LED. After the reaction, it was separated and purified by column chromatography, and the volume ratio of petroleum ether and ethyl acetate in the column chromatography eluent was 15:1 to obtain the purified target product with a yield of 45% and a purity of 99.9%;

[0339] The structure of the obtained product was characterized, and the structural characterization data are as follows:

[0340] 1 H NMR (400MHz, CDCl3, ppm) δ7.44-7.34(m,5H),6.74(s,1H),2.31(ddd,J=12.4,7.8,4.5Hz,1H),2.03(ddd,J=13 .5,8.4,5.0Hz,1H),1.14(p,J=3.9Hz,2H),1.03-0.98(m,2H),0.94(dt,J=7.4,3.8Hz,2H),0.87-0.80(m,2H);

[0341] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ190.9,155.4,141.0,140.7,128.7,128.2,125.8,108.6,19.9,12.0,9.0,8.2;

[0342] MS(EI,70eV)m / z 252,226,183,116,77;

[0343] HRMS (ESI) m / z [M+H] + Calculate for C 16 H 17 N2O 253.1335, found 253.1346.

[0344] Although the above embodiments have been described in detail for the present invention, they are only some embodiments of the present invention, rather than all embodiments. Other embodiments can be obtained based on the embodiments of the present invention without inventiveness, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A method for preparing a 1,3,5-trisubstituted pyrazole compound, characterized in that: The following steps are involved: A hydrazine compound, an α-bromoketone compound, a photocatalyst, a basic compound, an additive and a polar organic solvent are mixed, and an addition cyclization reaction is carried out under light conditions to obtain the 1,3,5-trisubstituted pyrazole compound; The hydrazine compound has a structure shown in Formula I: The R1 is an aryl group, a substituted aryl group, or a heteroaryl group; The α-bromoketone compound has a structure shown in Formula II: R2 is aryl, substituted aryl, heteroaryl or alkyl; The 1,3,5-trisubstituted pyrazole compound has a structure shown in Formula III: The additive includes one or more of sodium benzenesulfinate, sodium 4-methylbenzenesulfinate and sodium 4-fluorobenzenesulfinate.

2. The preparation method according to claim 1, characterized in that: The R1 is phenyl, substituted phenyl, pyridyl or naphthyl; the R2 is phenyl, substituted phenyl, pyridyl, thienyl, naphthyl or cycloalkyl.

3. The preparation method according to claim 2, characterized in that: The substituents in the substituted phenyl groups in R1 and R2 independently include halogen, cyano, methoxy, trifluoromethyl or methyl.

4. The preparation method according to claim 1 or 2, characterized in that: The hydrazine compound includes one or more of phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-methoxyphenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-trifluoromethylphenylhydrazine, 3-methylphenylhydrazine, 2-fluorophenylhydrazine, 2-chlorophenylhydrazine, 2-bromophenylhydrazine, 2-methylphenylhydrazine, 2-hydrazinepyridine and 2-naphthyhydrazine.

5. The preparation method according to claim 1 or 2, characterized in that: The α-bromo ketone compound includes one or more of 2-bromoacetophenone, 2-bromo-4'-(trifluoromethyl)acetophenone, 2-bromo-4'-fluoroacetophenone, 2-bromo-4'-chloroacetophenone, 2,4'-dibromoacetophenone, 2-bromo-4'-iodoacetophenone, 2-bromo-4'-methylacetophenone, 2-bromo-4'-methoxyacetophenone, 2,3'-dibromoacetophenone, 2-bromo-2'-chloroacetophenone, 2-bromo-3',4'-dimethoxyacetophenone, 2-bromo-5'-fluoro-2'-methoxyacetophenone, 2-(2-bromoacetyl)pyridine, 2-(2-bromoacetyl)thiophene, 2-(2-bromoacetyl)naphthalene and α-bromocyclopropylacetophenone.

6. The preparation method according to claim 1, characterized in that: The molar ratio of the hydrazine compound to the α-bromoketone compound is 1:2-4.

7. The preparation method according to claim 1, characterized in that: The photocatalyst includes a metal photocatalyst and / or a non-metal photocatalyst; the metal photocatalyst includes Ru(pby)3 and / or Ir[dF(CF3)ppy]2(dtbbpy)PF6; the non-metal photocatalyst includes one or more of Bengal rose red, rhodamine B and 4CzIPN.

8. The preparation method according to claim 1 or 6, characterized in that: The molar ratio of the hydrazine compound to the additive is 1:2-4.

9. The preparation method according to claim 1, characterized in that: The illumination is 10W blue LED; the temperature of the addition cyclization reaction is room temperature, and the time is 12 to 24 hours.

10. 1,3,5-trisubstituted pyrazole compounds, the structural formula of which is shown in any of the following structures:

Citation Information

Patent Citations

  • Pyrazole compounds and pharmaceutical compositions comprising the compound

    CN1656079A

  • Derivatives of 1-phenyl-3-phenylpyrazole as herbicides

    WO2003076409A1